Short answer
Tectonic Therapeutic, Inc. (TECX) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events). Timothy A. Springer and Stefan Vitorovic elected Class II directors through the 2029 annual meeting.
Tectonic Therapeutic, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Timothy A. Springer and Stefan Vitorovic elected Class II directors through the 2029 annual meeting
- Springer received 11,461,485 votes for versus 2,963,750 withheld
- Stefan Vitorovic received 13,937,996 votes for versus 487,239 withheld
- Deloitte & Touche LLP ratified as independent auditor for fiscal year ending December 31, 2026
- Executive compensation approved advisory basis, with 14,292,497 votes for and 118,271 against
Item 8.01 · Other Events
- Enrollment completed in TX45 APEX Phase 2 trial for PH-HFpEF patients
- Milestone reduces enrollment uncertainty and supports progression toward topline clinical data
- Press release dated June 10, 2026 contains trial details and management commentary
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tectonic Therapeutic, Inc. 8-K filings
Get the next TECX 8-K as it lands
Follow TECX for push alerts, or ask the research agent what this filing means.